Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability

Shubin, Z; Stanfield-Oakley, S; Puangkaew, J; Pitisutthithum, P; Nitayaphan, S; Gurunathan, S; Sinangil, F; Chariyalertsak, S; Phanuphak, N; Ake, JA; O'Connell, RJ; Vasan, S; Akapirat, S; Eller, MA; Ferrari, G; Paquin-Proulx, D

Paquin-Proulx, D (通讯作者),503 Robert Grant Ave, Silver Spring, MD 20910 USA.

AIDS, 2023; 37 (10): 1519

Abstract

Objectives:The RV144 vaccine trial resulted in a decreased risk of HIV acquisition that was associated with a nonneutralizing antibody response. The o......

Full Text Link